The availability of quick, accurate blood tests that can help rule out pre-eclampsia (PE) is improving care for pregnant women and their unborn babies, reducing anxiety and saving the NHS money. The Oxford Academic Science Network, who have been championing the use of PlGF-based testing, have worked with the Sustainable Healthcare Coalition to appraise the Continue reading “Environmental Impact of PlGF-based testing for pre-eclampsia”
Resource Category Archives
Environmental Impact and Benefits of Care4Today Total Knee Replacement Care Pathway
Environmental Impact and Benefits of Care4Today Total Knee Replacement Care Pathway This new case study from Johnson & Johnson demonstrates the value of assessing care pathways with an environmental impact lens. It reinforces value-based healthcare, in that improved health outcomes following knee replacement surgery using Care4Today®, a digital care pathway programme, correlate with a reduced Continue reading “Environmental Impact and Benefits of Care4Today Total Knee Replacement Care Pathway”
Care pathway for Monoclonal Antibody Therapy
Care pathway for Monoclonal Antibody Therapy of Severe Eosinophilic Asthma The use of Monoclonal Antibody (Mab) therapy is relatively new and evolving, but promises to revolutionise the management of asthma. This study by AstraZeneca has demonstrated the value of appraising the sustainability of care pathways using SHC’s guidance. The assessment has identified the environmental hotspots Continue reading “Care pathway for Monoclonal Antibody Therapy”
Decarbonisation of CKD treatment in the UAE
A discussion paper. It is recognised that global health and care systems are undergoing transformative change to adapt to the needs of patients and communities, with increasing pressure to be financially, socially and environmentally sustainable. Appraising the sustainability of care pathways is seen as a crucial step to enabling a more sustainable health system. As Continue reading “Decarbonisation of CKD treatment in the UAE”
Decarbonising Clinical Trials at Novartis
Novartis has embedded environmental sustainability across the clinical trial lifecycle, from protocol design through to close-out. This case study explains the overall approach and provides details around three targeted initiatives (investigational medication distribution, reusable shipping boxes, and clinical sample management) which are delivering significant operational, environmental, and financial benefits.
